ArticleBMC gastroenterology2026

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

Ibrahiem Amer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.